Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
Wright State University Boonshoft School of Medicine, Population and Public Health Sciences, Dayton, OH, USA.
J Racial Ethn Health Disparities. 2023 Aug;10(4):1910-1917. doi: 10.1007/s40615-022-01373-9. Epub 2022 Jul 25.
The purpose of this pilot study was to explore the effect of HIV-related stigma and everyday major experiences of discrimination on medication and clinic visit adherence among older African Americans living with HIV in Ohio.
We collected data from 53 individuals who were living with HIV in Ohio, ≥ 50 years of age, and who identified as Black or African American. We conducted logistic regression models to examine the impact of HIV-related stigma and experiences of discrimination on medication and visit adherence. Each model controlled for age, time since diagnosis, and sexual orientation.
The average age was 53.6 ± 2.1 years and 94.3% were men. Almost half (49.1%) of the participants reported poor medication adherence and almost a third (31.4%) reported poor visit adherence. HIV-related stigma (adjusted odds ratio (aOR) = 1.39; 95% confidence interval (CI) = 1.02-1.89) and major experiences of discrimination (aOR = 1.70; 95% CI = 1.11-2.60) were associated with a greater odds of poor medication adherence. Additionally, major experiences of discrimination were associated with a threefold increase in the odds of poor visit adherence (aOR = 3.24; 95% CI = 1.38-7.64).
HIV-related stigma and major experiences of discrimination impede optimal medication and HIV clinic visit adherence for older African Americans living with HIV. To reduce the impact of stigma and discrimination on HIV care engagement, our first step must be in understanding how intersecting forms of stigma and discrimination impact engagement among older African Americans living with HIV.
本初步研究旨在探讨艾滋病毒相关耻辱感和日常遭受的重大歧视经历对俄亥俄州老年艾滋病毒感染者坚持药物治疗和就诊的影响。
我们收集了俄亥俄州 53 名年龄在 50 岁及以上、自我认同为黑人或非裔美国人的艾滋病毒感染者的数据。我们采用逻辑回归模型来检验艾滋病毒相关耻辱感和歧视经历对药物治疗和就诊依从性的影响。每个模型都控制了年龄、诊断后时间和性取向。
平均年龄为 53.6±2.1 岁,94.3%为男性。近一半(49.1%)的参与者报告药物治疗依从性差,近三分之一(31.4%)报告就诊依从性差。艾滋病毒相关耻辱感(调整后的优势比(aOR)=1.39;95%置信区间(CI)=1.02-1.89)和重大歧视经历(aOR=1.70;95%CI=1.11-2.60)与较差的药物治疗依从性的可能性更大相关。此外,重大歧视经历与较差就诊依从性的可能性增加三倍相关(aOR=3.24;95%CI=1.38-7.64)。
艾滋病毒相关耻辱感和重大歧视经历会妨碍老年非裔美国艾滋病毒感染者的最佳药物治疗和艾滋病毒就诊依从性。为了减少耻辱感和歧视对艾滋病毒护理参与的影响,我们必须首先了解多种形式的耻辱感和歧视如何影响老年非裔美国艾滋病毒感染者的参与。